GSTP1 Human Recombinant fused with 36 amino acid His tag at N-terminus produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 246 amino acids
(1-210 a.a.) And having a molecular mass of 27.4kDa.
The GSTP1 is purified by proprietary chromatographic techniques.
MRGSHHHHHH GMASMTGGQQ MGRDLYDDDD KDRWGSMPPY TVVYFPVRGR CAALRMLLAD QGQSWKEEVV TVETWQEGSL KASCLYGQLP KFQDGDLTLY QSNTILRHLG RTLGLYGKDQ QEAALVDMVN DGVEDLRCKY ISLIYTNYEA GKDDYVKALP GQLKPFETLL SQNQGGKTFI VGDQISFADY NLLDLLLIHE VLAPGCLDAF PLLSAYVGRL SARPKLKAFL ASPEYVNLPI NGNGKQ.
Glutathione S-Transferase pi 1 (GSTP1) is a member of the glutathione S-transferase (GST) family, which plays a crucial role in the detoxification process by catalyzing the conjugation of reduced glutathione to various electrophilic compounds. This enzyme is encoded by the GSTP1 gene in humans and is involved in the metabolism of xenobiotics and protection against oxidative stress.
The GSTP1 gene is located on chromosome 11q13 and is known to be polymorphic, encoding functionally different variant proteins . These variants are thought to influence an individual’s susceptibility to various diseases, including cancer . The GSTP1 protein is a cytosolic enzyme that belongs to the pi class of GSTs, which also includes alpha, mu, and theta classes .
GSTP1 plays a significant role in the detoxification of endogenous and exogenous compounds. It catalyzes the conjugation of glutathione to a wide range of substrates, including environmental toxins, carcinogens, and products of oxidative stress . This process helps in the neutralization and elimination of harmful compounds from the body.
The polymorphic nature of the GSTP1 gene has been associated with varying levels of enzyme activity and, consequently, different susceptibilities to diseases. For instance, certain GSTP1 variants have been linked to an increased risk of developing cancers, such as lung, breast, and prostate cancer . Additionally, GSTP1 is being studied as a potential drug target for cancer therapy, particularly in triple-negative breast cancer .
Recombinant GSTP1 is produced using recombinant DNA technology, which involves inserting the GSTP1 gene into an expression vector and introducing it into a host cell, such as E. coli, for protein production. This recombinant protein is used in various research applications, including studies on enzyme kinetics, drug metabolism, and the development of GSTP1 inhibitors for therapeutic purposes .